Coalition including California, Colorado push for federal cannabis reclassification

Cannabis found inside of an adult diaper discovered at LaGuardia Airport.
Courtesy of TSA

(Kenneth Schrupp) – Colorado, California and 10 other state attorneys general called upon the U.S. Drug Enforcement Administration to classify cannabis as safe for medical research, potentially paving the way for next steps towards federal cannabis decriminalization.

The DEA currently classifies cannabis as a Schedule I substance, which means it is recognized as a substance with high potential for abuse, no currently accepted medical use, and lack of accepted safety for use under medical supervision. Other Schedule I substances include heroin, LSD and MDMA. Moving cannabis to Schedule III would mean recognizing cannabis as having a moderate to low potential for abuse and a currently accepted medical use. Schedule III substances include ketamine, testosterone, and barbiturates.

“While we are not all aligned on the wisdom of fully legalizing cannabis, we do agree, however, that a state-regulated cannabis industry better protects consumers than the illicit marijuana market or the unregulated intoxicating hemp-derived marketplace,” wrote the 12 attorneys general in their letter to the DEA.

Tuesday’s news < 10 minutesclose

Next

Stay

volume_off

-5:43

sd

share

closed_caption

fullscreen

Auto (225p)

225p

360p

Subtitles Off

Subtitles EN

English

Guide dog named in honor of NFL star Eli Manning

1:33

Tuesday’s news < 10 minutes

5:43

Serbian archeologists unearth ancient Roman arch

0:59

Dior designer spotlights moire on Paris runway

1:07

Monday’s news < 10 minutes

4:55

British drivers tackle muddy hills in unusual race

1:09

Paraplegic adventurer to sit-ski across the South Pole

1:33

Remembering past top prospects

2:32

Karl Marx’s London cemetery seeks new lease of life

1:32

Croatian driver offers free rides on vintage bus

1:20

arrow_back_ios_new

arrow_forward_ios

The letter also claims that the regulated cannabis marketplace will exceed $53 billion in 2027, serving as a boon for state and federal tax revenue, and that current classification prevents cannabis business owners from taking tax deductions that could be used to improve public health and law enforcement outcomes.

“Because Section 280E of the Internal Revenue Code prohibits anyone violating Schedules I or II of the Controlled Substances Act from taking ordinary business deductions, moving marijuana to Schedule III will remove a major obstacle for legitimate cannabis operators. Eliminating this tax burden via re-scheduling will allow licensed, regulated cannabis companies to expand their investments into the state programs and focus on public health and safety in collaboration with law enforcements [sic] efforts,” continued the letter.

The SAFE Banking Act, which would have protected banks from penalties for servicing cannabis businesses where legal, was introduced in 2023 but failed to advance.

By

Kenneth Schrupp | The Center Square